Novel Gene Discovery in Cardiomyopathy
Submission Deadline: 1 Sep 2022
Guest Editor

John Lynn Jefferies MD, MPH, FACC, FAHA, FHFSA, FESC
School of Public Health, University of Memphis, Memphis, TN, USA
Interests: Advanced heart failure; cardiomyopathy; mechanical circulatory support and transplant; Heritable causes of vascular disease; novel drug therapies for advanced heart failure; novel gene discovery in cardiomyopathy; characterization and management of left ventricular noncompaction (LVNC); early diagnosis and management of chemotherapy
Special Issue Information
Dear Colleagues,
The past decade has seen a tremendous amount of literature describing genetic triggers of cardiovascular disease. Genetic underpinnings have been reported across the spectrum of cardiology including arrhythmias, coronary artery disease, vascular disease, dyslipidemia, and myocardial dysfunction. The Special Issue “Novel Gene Discovery in Cardiomyopathy” will collect high-quality original research papers and comprehensive reviews on recent advances in our understanding of the genetics that drive cardiomyopathy phenotypes. These findings have important implications as they help us to understand mechanisms and potential targets for therapy. Furthermore, the understanding of heritable disease facilitates the screening of appropriate at-risk family members. The topics of interest include, but are not limited to:
● Dilated cardiomyopathy
● Hypertrophic cardiomyopathy
● Restrictive cardiomyopathy
● Arrhythmogenic cardiomyopathy
● Non-compaction cardiomyopathy
● Cardiomyopathies associated with rare disorders or syndromic disease
Manuscripts submitted to the Special Issue will be subjected to stringent selection criteria to ensure the privileged position of accepted contributions. Those that fail to pass the selection will be considered for publication in RCM as regular contributions.
Prof. Dr. John Lynn Jefferies
Guest Editor
Keywords
- Cardiomyopathy
- Dilated
- Hypertrophic
- Arrhythmogenic
- Restrictive
- Non-compaction
- Gene
- Cardiovascular genetics
- Genomics
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Paper (1)
Genotype-Phenotype Associations with Restrictive Cardiomyopathy Induced by Pathogenic Genetic Mutations
Rev. Cardiovasc. Med. 2022, 23(6), 185; https://doi.org/10.31083/j.rcm2306185
(This article belongs to the Special Issue Novel Gene Discovery in Cardiomyopathy)
